Classification and natural history of the neuronal ceroid lipofuscinoses

Journal of Child Neurology

Volumn 28, Issue 9, 2013, Pages 1101-1105

  Mink, Jonathan W ^a   Augustine, Erika F ^a   Adams, Heather R ^a   Marshall, Frederick J ^a   Kwon, Jennifer M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Batten disease; blindness; dementia; epilepsy; movement disorders; neurodegeneration

Indexed keywords

ARTICLE; CLN1 DISEASE; CLN10 DISEASE; CLN2 DISEASE; CLN3 DISEASE; CLN4 DISEASE; CLN5 DISEASE; CLN6 DISEASE; CLN7 DISEASE; CLN8 DISEASE; CLN9 DISEASE; DISEASE CLASSIFICATION; GENE MUTATION; HISTORY OF MEDICINE; HUMAN; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL;

BATTEN DISEASE; BLINDNESS; DEMENTIA; EPILEPSY; MOVEMENT DISORDERS; NEURODEGENERATION;

HUMANS; NEURONAL CEROID-LIPOFUSCINOSES; PHENOTYPE;

EID: 84883671456     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813494268     Document Type: Article

References (45)

1. Mole SE, Williams RE, Goebel HH The Neuronal Ceroid Lipofusinoses. 2 nd ed. Oxford: Oxford University Press; 2011. Oxford: Oxford University Press ; 2011 :
2. Stengel OC. Beretning om et maerkeligt Sygdomstilfaelde hos fire Sødskende I Nærheden af Röraas. Eyr. 1826 ; 1: 347-352
3. Batten FE. Cerebral degeneration with symmetrical changes in the maculae in two members of a family. Trans Ophthalmol Soc UK. 1903 ; 23: 386-390
4. Spielmeyer W. Über familiäre amaurotische Idiotien. Neurol Cbl. 1905 ; 24: 620-612
5. Vogt H. Über familiäre amaurotische Idiotie und verwandte Krankheitsbilder. Mschr Psychiatr Neurol. 1905 ; 18: 161-171
6. Janský J. Dosud nepopsaný pripad familiárni amaurotické idiotie komplikované s hypoplasii mozeckovou. Sborn Lék. 1908 ; 13: 165-196
7. Bielschowsky M. Über spätinfantile familiäre amaurotische Idiotie mit Kleinhirnsymptonen. Deutsche Zeitschrift für Nervenheilkunde. 1913 ; 50: 7-29
8. Kufs H. Über eine Spätform der amaurotischen Idiotie und ihre heredofamiliären Grundlagen. Z Ges Neurol Psychiatr. 1925 ; 95: 168-188
9. Haltia M, Rapola J, Santavuori P, Keranen A.. Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies. J Neurol Sci. 1973 ; 18: 269-285
10. Santavuori P, Haltia M, Rapola J, Raitta C.. Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J Neurol Sci. 1973 ; 18: 257-267
11. Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003 ; 62: 1-13
12. Williams RE, Goebel HH, Mole SE, et al The Neuronal Ceroid Lipofuscinoses (Batten Disease). 2 nd ed. Oxford: Oxford University Press; 2011:20-23. Mole SE Williams RE Goebel HH, ed. Oxford: Oxford University Press ; 2011: 20-23.
13. Williams RE, Mole SE. New nomenclature and classification scheme for the neuronal ceroid lipofusicnoses. Neurology. 2012 ; 79: 183-191
14. Berkovic SF, Carpenter S, Andermann F, et al. Kufs' disease: a critical reappraisal. Brain. 1988 ; 111 (pt 1). 27-62
15. Vesa J, Hellsten E, Verkruyse LA, et al. Mutations in the palmityl protein thioesterase gene causing late infantile neuronal ceroid lipofuscinosis. Nature. 1995 ; 376: 584-587
16. Santavuori P, Haltia M, Rapola J. Infantile type of so-called neuronal ceroid-lipofuscinosis. Dev Med Child Neurol. 1974 ; 16: 644-653
17. Vanhanen SL, Puranen J, Autti T, et al. Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics. 2004 ; 35: 27-35
18. Becker K, Goebel HH, Svennerholm L, et al. Clinical, morphological, and biochemical investigations on a patient with an unusual form of neuronal ceroid-lipofuscinosis. Eur J Pediatr. 1979 ; 132: 197-206
19. Das AK, Becerra CH, Yi W, et al. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest. 1998 ; 102: 361-370
20. Wisniewski KE, Connell F, Kaczmarski W, et al. Palmitoyl-protein thioesterase deficiency in a novel granular variant of LINCL. Pediatr Neurol. 1998 ; 18: 119-123
21. van Diggelen OP, Thobois S, Tilikete C, et al. Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol. 2001 ; 50: 269-272
22. Ramadan H, Al-Din AS, Ismail A, et al. Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1. Neurology. 2007 ; 68: 387-388
23. Das A. Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum Mol Genet. 2001 ; 10: 1431-1439
24. Golabek AA, Walus M, Wisniewski KE, Kida E. Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo. J Biol Chem. 2005 ; 280: 7550-7561
25. Steinfeld R, Heim P, von Gregory H, et al. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet. 2002 ; 112: 347-354
26. Brodsky MC, Baker RS, Hamed LM Pediatric Neuro-Ophthalmology. New York: Springer-Verlag ; 1996 :
27. Taratuto AL, Saccoliti M, Sevlever G, et al. Childhood neuronal ceroid-lipofuscinoses in Argentina. Am J Med Genet. 1995 ; 57: 144-149
28. Adams HR, Beck CA, Levy E, et al. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease). Dev Med Child Neurol. 2010 ; 52: 637-643
29. Kwon JM, Adams H, Rothberg PG, et al. Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology. 2011 ; 77: 1801-1807
30. Cialone J, Adams H, Augustine EF, et al. Females experience a more severe disease course in Batten disease. J Inherit Metab Dis. 2012 ; 35: 549-555
31. Nielsen AK, Ostergaard JR. Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience. Eur J Paediatr Neurol. 2013 ; 17: 265-268
32. Ostergaard JR, Rasmussen TB, Molgaard H. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology. 2011 ; 76: 1245-1251
33. Boehme DH, Cottrell JC, Leonberg SC, Zeman W. A dominant form of neuronal ceroid-lipofuscinosis. Brain. 1971 ; 94: 745-760
34. Santavuori P, Rapola J, Sainio K, Raitta C. A variant of Jansky-Bielschowsky disease. Neuropediatrics. 1982 ; 13: 135-141
35. Xin W, Mullen TE, Kiely R, et al. CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL. Neurology. 2010 ; 74: 565-571
36. Gao H, Boustany RM, Espinola JA, et al. Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet. 2002 ; 70: 324-335
37. Mole S, Williams R, Goebel H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005 ; 6: 107-126
38. Arsov T, Smith KR, Damiano J, et al. Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet. 2011 ; 88: 566-573
39. Berkovic SF, Andermann F, Andermann E, et al. Kufs disease: clinical features and forms. Am J Med Genet Suppl. 1988 ; 5: 105-109
40. Topcu M, Tan H, Yalnizoglu D, et al. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr. 2004 ; 46: 1-10
41. Kousi M, Siintola E, Dvorakova L, et al. Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Brain. 2009 ; 132 (pt 3). 810-819
42. Mitchell WA, Wheeler RB, Sharp JD, et al. Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8. Eur J Paediatr Neurol. 2001 ; 5 (suppl A). 21-27
43. Ranta S, Lehesjoki AE. Northern epilepsy, a new member of the NCL family. Neurol Sci. 2000 ; 21: S43 - S47
44. Steinfeld R, Reinhardt K, Schreiber K, et al. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet. 2006 ; 78: 988-998
45. de Blieck EA, Augustine EF, Marshall FJ, et al. Methodology of clinical research in rare diseases: Development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates. Contemp Clin Trials. 2013 ; 35: 48-54